본문 바로가기
KERD
논문KCI 등재

호중구 감소성 발열을 보이는 소아 암 환자에서의 요로감염에 대한 연구

Urinary tract infections in pediatric oncology patients with febrile neutropenia

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

Background: Neutropenic fever is one of the most common and potentially severe complications of chemotherapy in pediatric oncology patients, while urinary tract infection (UTI) is one of the most prevalent bacterial infections in these patients. Therefore, this study was conducted to investigate features of UTI with neutropenic fever in pediatric oncology patients. Methods: We retrospectively reviewed and analyzed the medical records, laboratory results and image findings of cases of neutropenic fever in the Department of Pediatrics of Yeungnam University Medical Center, South Korea between November 2013 and May 2015. Episodes were divided into two groups, UTI vs. non- UTI group according to the results of urine culture. The results were then compared between groups. The analysis was performed using IBM SPSS 23.0. A p-value <0.05 was considered to indicate a significant difference between groups. Results: Overall, 112 episodes of neutropenic fever were analyzed, among which 22 episodes (19.6%) showed organisms on urine culture and were classified as UTI. The remaining 90 episodes were classified as non- UTI. Only four episodes (18.2%) of the UTI group showed pyuria on urine analysis. In the UTI group, 76.5% were sensitive to the first line antibiotics and showed higher clinical response than the non-UTI group. Among hematologic malignancy patients, the UTI group revealed higher serum β 2-microglobulin levels than the non-UTI group (1.56±0.43 mg/L vs. 1.2±0.43 mg/L, p<0.028). Conclusion: UTI in pediatric neutropenic fever responds well to antibiotics. Hematologic malignancy cases with UTI reveal increased serum β 2-microglobulin level. These results will be helpful to early phase diagnosis of UTI.

Abstract

Background: Neutropenic fever is one of the most common and potentially severe complications of chemotherapy in pediatric oncology patients, while urinary tract infection (UTI) is one of the most prevalent bacterial infections in these patients. Therefore, this study was conducted to investigate features of UTI with neutropenic fever in pediatric oncology patients. Methods: We retrospectively reviewed and analyzed the medical records, laboratory results and image findings of cases of neutropenic fever in the Department of Pediatrics of Yeungnam University Medical Center, South Korea between November 2013 and May 2015. Episodes were divided into two groups, UTI vs. non- UTI group according to the results of urine culture. The results were then compared between groups. The analysis was performed using IBM SPSS 23.0. A p-value <0.05 was considered to indicate a significant difference between groups. Results: Overall, 112 episodes of neutropenic fever were analyzed, among which 22 episodes (19.6%) showed organisms on urine culture and were classified as UTI. The remaining 90 episodes were classified as non- UTI. Only four episodes (18.2%) of the UTI group showed pyuria on urine analysis. In the UTI group, 76.5% were sensitive to the first line antibiotics and showed higher clinical response than the non-UTI group. Among hematologic malignancy patients, the UTI group revealed higher serum β 2-microglobulin levels than the non-UTI group (1.56±0.43 mg/L vs. 1.2±0.43 mg/L, p<0.028). Conclusion: UTI in pediatric neutropenic fever responds well to antibiotics. Hematologic malignancy cases with UTI reveal increased serum β 2-microglobulin level. These results will be helpful to early phase diagnosis of UTI.

참고문헌 (25)

  1. Lehrnbecher T, "Guideline for the management of fever and neutropenia in children with cancer and", or undergoing hematopoietic stem-cell transplantation, 2012, pp.30, 4427~4438
  2. Miedema KG, "Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study", Eur J Cancer, 53, pp.16~24 (2016)
  3. Tezcan G, "Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey", Pediatr Hematol Oncol, 23, pp.217~229 (2006)
  4. Bakhshi S, "Infections in childhood acute lymphoblastic leukemia: an analysis of 222 febrile neutropenic episodes", Pediatr Hematol Oncol, 25, pp.385~392 (2008)
  5. Lohr JA, "Making a presumptive diagnosis of urinary tract infection by using a urinalysis performed in an on-site laboratory", J Pediatr, 122, pp.22~25 (1993)
  6. Urabe A., "Clinical features of the neutropenic host: definitions and initial evaluation", Clin Infect Dis, 39(Suppl 1), pp.S53~S55 (2004)
  7. Klaassen IL, "Pyuria is absent during urinary tract infections in neutropenic patients", Pediatr Blood Cancer, 56, pp.868~870 (2011)
  8. Sandoval C, "Urinary tract infections in pediatric oncology patients with fever and neutropenia", Pediatr Hematol Oncol, 29, pp.68~72 (2012)
  9. Hughes WT, "2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer", Clin Infect Dis, 34, pp.730~751 (2002)
  10. Santolaya ME, "Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia", Clin Infect Dis, 35, pp.678~683 (2002)
  11. Wald E., "Urinary tract infections in infants and children: a comprehensive overview", Curr Opin Pediatr, 16, pp.85~88 (2004)
  12. 최림, "발열성 소아 요로감염에서 농뇨의 임상적 의의", Childhood Kidney Diseases, 15(1), pp.66~75 (2011), 대한소아신장학회
  13. Mulinde J, "The diagnostic and therapeutic approach to lower respiratory tract infections in the neutropenic patient", J Antimicrob Chemother, 41(Suppl D), pp.51~55 (1998)
  14. Mori R, "Diagnostic performance of urine dipstick testing in children with suspected UTI: a systematic review of relationship with age and comparison with microscopy", Acta Paediatr, 99, pp.581~584 (2010)
  15. Savory DJ., "Reference ranges for serum creatinine in infants, children and adolescents", Ann Clin Biochem, 27, pp.99~101 (1990)
  16. Clark LC Jr, "Excretion of creatine and creatinine by children", AMA Am J Dis Child, 81, pp.774~783 (1951)
  17. Ahlström A, "Evolution and predictive power of serum cystatin C in acute renal failure", Clin Nephrol, 62, pp.344~350 (2004)
  18. Haase-Fielitz A, "Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study", Crit Care Med, 37, pp.553~560 (2009)
  19. Herrero-Morín JD, "Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children", Crit Care, 11, pp.R59~ (2007)
  20. Yim HE, "Predictive value of urinary and serum biomarkers in young children with febrile urinary tract infections", Pediatr Nephrol, 29, pp.2181~2189 (2014)
  21. 심지현, "요로감염 소아에서 혈청 Cystatin C 측정의 임상적 적용", Childhood Kidney Diseases, 18(2), pp.85~91 (2014), 대한소아신장학회
  22. Ikezumi Y, "Establishment of a normal reference value for serum β2 microglobulin in Japanese children: reevaluation of its clinical usefulness", Clin Exp Nephrol, 17, pp.99~105 (2013)
  23. 조윤주, "2차 병원에서의 지역 사회 획득 요로 감염의 원인균 및 항생제 감수성 분석", Pediatric Infection and Vaccine, 17(1), pp.30~35 (2010), 대한소아감염학회
  24. Johnson JR, "Renal ultrasonographic correlates of acute pyelonephritis", Clin Infect Dis, 14, pp.15~22 (1992)
  25. Choi JY, "Power Doppler sonography for the upper urinary tract infection in children", Yeungnam Univ J Med, 24, pp.179~185 (2007)

관련 논문AI추천

이 간행물의 다른 논문 (18건)